HCPLive Network

Pulmonary Congestion Predicts Death, Cardiac Events in Renal Disease

FRIDAY, March 1 (HealthDay News) -- Pulmonary congestion can predict risk of death and cardiac events in patients with end-stage renal disease undergoing dialysis, according to a study published online Feb. 28 in the Journal of the American Society of Nephrology.

Carmine Zoccali, MD, from the National Research Council-Institute of Biomedicine, in Pisa, Italy, and colleagues used a well validated ultrasound B-lines score (BL-US) to measure the extravascular lung water in 392 patients with end-stage renal disease receiving hemodialysis at one of multiple centers.

The researchers found that 45 percent of participants had moderate-to-severe lung congestion and 14 percent had very severe congestion. Seventy-one percent of patients with moderate-to-severe lung congestion were asymptomatic or presented slight symptoms of heart failure. Compared with those patients having mild or no congestion, patients with very severe congestion had a 4.2-fold increased risk of death and a 3.2-fold increased risk of cardiac events, even after adjustments for New York Heart Association class. There was also a significant 10 percent improvement in risk reclassification for cardiac events with the inclusion of the degree of pulmonary congestion into the model.

"In summary, lung ultrasound can detect asymptomatic pulmonary congestion in hemodialysis patients, and the resulting BL-US score is a strong, independent predictor of death and cardiac events in this population," the authors write.

Full Text (subscription or payment may be required)

Copyright © 2013 HealthDay. All rights reserved.

Further Reading
Researchers at Wake Forest Baptist Medical Center have released a study showing the potential of a dangerous interaction between a common supplement and prescription medication.
Study results presented at CHEST 2013 show that patients given beta-blockers may actually be at increased risk of having an adverse cardiac event during a noncardiac surgical procedure.
Lowering sodium levels to moderate (2,300 mg/day) seems to result in improved health outcomes, but the evidence is insufficient to assess the benefits and harms of further lowering levels.
Intravenous treatment with the iron compound ferric carboxymaltose improves health-related quality of life in patients with chronic heart failure.
After finding abnormal elevations of cardiac inflammation in patients with depressive illness (DI), a psychiatrist at Loyola University Medical Center, in Maywood, Ill., has proposed a new subspecialty to diagnose and treat patients with both depression and cardiovascular disease (CVD).
For women without coronary heart disease at baseline, smoking, even in small quantities, is associated with a significantly increased risk of sudden cardiac death, according to research published online Dec. 11 in Circulation.
There is an increased risk of death from a myocardial infarction among adults who experience the death of a sibling, according to a study published online Feb. 27 in the Journal of the American Heart Association.
More Reading